CNE100002Q33
CNE100002Q33
KANGTAI BIOLOGICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 15.01B EUR | 12.67B EUR | 15.54B EUR |
Enterprise Value | 14.25B EUR | 14.29B EUR | 17.29B EUR |
Valuation Multiples | |||
Trailing P/E | 168x | 146.16x | 168.79x |
Forward P/E | 46.89x | -- | -- |
Price to Sales | 5.88x | 4.82x | 5.9x |
Price to Book | 1.56x | 1.31x | 1.61x |
EV/Revenue | 5.58x | 5.43x | 6.57x |
EV/EBITDA | 28.89x | 43.66x | 51.97x |
Price to FCF (P/FCF) | 385.55x | 177.38x | -- |
EV/FCF | 366.06x | 200.07x | -- |
FCF Yield | 0.26% | 0.56% | -1.09% |